Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with breast or colon cancer that has not spread to other parts of the body
- People aged between 40 and 70 years old
- People who have already begun chemotherapy or immunotherapy and still have at least three treatment sessions remaining in their current cycle
- People whose cancer-related physical functioning has been assessed as good (rated 0 or 1 on a standard scale used by doctors, meaning they are fully active or have only minor limitations in physical activity)
- People who are able to do moderate-intensity cycling exercise as directed by the trial, without experiencing pain from the bicycle seat
Who may not be able to join:
- People who have a bone, joint, heart, or metabolic condition (such as diabetes-related complications) that would make aerobic exercise unsafe for them
- People who have a health condition that is not currently under control
- People who are taking a type of medication called beta-blockers
- People who have surgery planned at any point during the study period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eléonor Riesco, PhD, University of Sherbrooke, Faculty of Physical Activity Sciences, Department of Kinanthropology
Phone: 819-821-8000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in migratory capacity of different peripheral blood mononuclear cells (Natural Killer Cells and T cells); Change in the concentration and characterization of subpopulations of migrated peripheral blood mononuclear cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.